These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10546462)

  • 1. [The effect of cost evaluation in the treatment of asthma].
    Sorli J
    Med Arh; 1999; 53(3 Suppl 1):15-7. PubMed ID: 10546462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children.
    Barnes NC; Thwaites RM; Price MJ
    Respir Med; 1999 Jun; 93(6):402-7. PubMed ID: 10464822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
    Ostrom NK; Decotiis BA; Lincourt WR; Edwards LD; Hanson KM; Carranza Rosenzweig JR; Crim C
    J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
    Pharmacoeconomics; 1999; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
    Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness of fluticasone propionate for asthma episodes in Japanese patients with asthma--Fluticasone Investigation of Asthma Episode (FINE) study].
    Miyamoto T; Morita Y; Tamura G; Tohda Y; Arakawa I; Shiragami M
    Arerugi; 2006 May; 55(5):542-53. PubMed ID: 16883092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.
    Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma.
    Ericsson K; Bantje TA; Huber RM; Borg S; Bateman ED
    Respir Med; 2006 Apr; 100(4):586-94. PubMed ID: 16274980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.
    Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB
    J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-efficacy comparison of inhaled fluticasone propionate and budesonide in the treatment of asthma.
    Stempel DA; Stanford RH; Thwaites R; Price MJ
    Clin Ther; 2000 Dec; 22(12):1562-74. PubMed ID: 11192147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
    Harmanci E; Ak I; Ozdemir N; Vardareli E; Elbek O; Uçgun I
    Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
    Stempel DA; Mauskopf J; McLaughlin T; Yazdani C; Stanford RH
    Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
    Stempel DA; Kruzikas DT; Manjunath R
    J Pediatr; 2007 Feb; 150(2):162-7. PubMed ID: 17236894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory therapy reduces total costs of asthma care compared with bronchodilation: the Asthma Outcomes Registry.
    Huse DM; Russell MW; Weiss ST; Hartz SC
    Am J Manag Care; 2000 Sep; 6(9):1045-50. PubMed ID: 11184066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
    Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
    Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to make easier the treatment of asthma].
    Ait-Khaled N
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S76-10S79. PubMed ID: 17127972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.